Testing the Addition of Nivolumab to Chemotherapy for Patients With Metastatic Anal Cancer
Conditions: Anal Basaloid Carcinoma; Anal Canal Cloacogenic Carcinoma; Metastatic Anal Squamous Cell Carcinoma; Recurrent Anal Squamous Cell Carcinoma; Stage III Anal Cancer AJCC v8; Stage IIIA Anal Cancer AJCC v8; Stage IIIB Anal Cancer AJCC v8; Stage IIIC Anal Cancer AJCC v8; Stage IV Anal Cancer AJCC v8 Interventions: Drug: Carboplatin; Biological: Nivolumab; Drug: Paclitaxel Sponsor: National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials